| Affiliation: | 1. Department of Clinical Pharmacology, Hospices Civils de Lyon, Lyon, France; UMR 5558, CNRS, Villeurbanne, France; Claude Bernard Lyon 1 University, Lyon, France;2. Department of Cardiology, Centre Hospitalier Universitaire, Grenoble, France; INSERM 1039, Bioclinic Radiopharmaceutics Laboratory, Joseph Fourier University, Grenoble, France;3. Department of General Practice, Claude Bernard Lyon 1 University, Lyon, France;4. Plurithematic Clinical Investigation Centre, CIC-P-Inserm CHU de Nancy, Lorraine Institute of Heart and Vessels Louis Mathieu, Vand?uvre-lès-Nancy, France; Henri Poincaré Nancy University, France;5. Department of General Practice, Faculty of Medicine, Rouen University, Rouen, France; CIC Inserm 0204, CHU of Rouen, Rouen, France;6. Vascular Functionnal Exploration Laboratory, CHU Angers, Angers, France;7. Arnaud de Villeneuve Hospital, CHU Montpellier, Montpellier, France;8. Department of Nephrology and Hypertension, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France;9. Clinical Investigation Center, CIC 201, INSERM, Lyon, France;10. Endocrine and Metabolic Function Exploration, Centre of Biology North, Croix-Rousse Hospital, Hospices Civils de Lyon, Lyon, France;11. Clinical Investigation Centre, CIC 201 Inserm and Department of Clinical Pharmacology, Hospices Civils de Lyon, Lyon, France; UMR 5558, CNRS, Villeurbanne, France; Claude Bernard Lyon 1 University, Lyon, France;1. Service de Pharmacologie médicale et Toxicologie, Centre d’Addictovigilance, Hôpital Lapeyronie, CHU Montpellier, UM1, Montpellier, France;2. Unité de Traitement des Toxicodépendances, Médecine interne E, Addictologie, Hôpital Saint Eloi, CHU Montpellier, UM1, Montpellier, France;3. Unité de Recherche clinique et Épidémiologie, Hôpital la Colombière, CHU Montpellier, UM1, Montpellier, France |
